MB-PhDs
Study a fully-funded PhD alongside your medical degree
What is an MB-PhD?
Our MB-PhD studentship allows aspiring clinical scientists and academics to undertake medical degree training in tandem with the research expertise of a PhD in Cancer Sciences, leading to the joint award of an MBChB and PhD.
Why do an MB-PhD?
- Graduate with an MBChB and a PhD
- Have your PhD and undergraduate MBChB fees paid*
- Receive an annual stipend to help with your living costs
- Gain the skills, knowledge and training to drive new innovations in clinical care and become a future cancer research leader
- Receive mentorship and training from world-leading academic clinicians and cancer scientists
*Take a look at our policy document (PDF, 1MB) for more information on how we support your return to undergraduate medical studies following completion of your PhD and for further details about our undergraduate tuition fee bursary.
The PhD component of the MB-PhD studentship is usually funded for three years, or four years in exceptional circumstances with prior agreement of MB-PhD Committee and supervisory team.
The studentship covers:
- An annual stipend of £22,113 per year to help with living costs
- Full funding for your PhD tuition fees (at the UK rate, with fee bursaries available for high-performing EU/International candidates)
- PhD project consumables and running costs, including costs for researcher development such as conferences and travel
- MBChB tuition fees (at the UK rate) up to a maximum of £45,000 per student inclusive of interest.
Please speak to the MCRC Training Office regarding individual calculations as these could vary from the stated amount, dependent on how and what fees have been paid. These are conditional upon completion of MBChB and PhD components.
To apply to intercalate onto the PhD in Cancer Sciences component of the MB-PhD, you must meet the below criteria and satisfy the general requirements for permission to intercalate set by your institution, including passing all components of the MBChB at first attempt in the year prior to intercalation.
A University of Manchester MBChB student
- holding a BSc (hons) 2.1 or above in a relevant subject and in year 2 or year 3 of the MBChB or year 1 or year 2 of GEM; or
- currently studying in year 3 of the MBChB or year 2 of GEM
A University of St Andrews Medicine BSc (Hons) student on the Manchester course pathway:
- holding or predicted a BSc (hons) 2.1 or above and be intending to intercalate straight onto the MB-PhD ahead of your arrival in Manchester or by no later than between year 3 and year 4 of the Manchester MBChB programme
A University of Leeds MBChB student:
- currently studying in year 3 of the MB ChB
International applicants (including EU nationals) must ensure they meet the relevant academic eligibility criteria (including English Language).
Navigation
Email a current MB-PhD student
Want to know more about our MB-PhD studentships? Vlasios Gourgiotis is an MB-PhD student and MB-PhD student rep. He is on hand to answer any questions you may have.
Clinical Research Training Fellowships
Discover our various opportunities for clinicians looking to undertake a period of PhD training in a cancer-relevant field.
Non-Clinical PhD Studentships
Learn more about our Non-Clinical PhD Studentships and other opportunities.
Nursing and Allied Health Professional Academic Pathways
This pathway allows nursing and allied health professionals (AHPs) to develop academic careers alongside their current clinical and managerial responsibilities.
RadNet Manchester AHP Doctoral Academy
RadNet Manchester is the only unit in CRUK’s radiation research network with a dedicated Doctoral Training Academy focused on the development of Allied Health Professionals working in radiotherapy research.
ACED PhD funding opportunities
Our ACED PhD Studentships will set you up as a future leader of cancer early detection.
Why Manchester?
See why our students choose to study in Manchester.